Humans with Pulmonary Arterial Hypertension display a global hypermethylation signature that worsens in patients who have a mutation in the gene encoding the methylation eraser, Tet Methylcytosine Dioxygenase 2 (TET2)
Charles C.T Hindmarch, François Potus, Al-Qazazi Ruaa, Brooke Ring, William C Nichols, Michael J Rauh, Stephen L Archer
doi: https://doi.org/10.1101/2023.08.09.23293846
Charles C.T Hindmarch
1Department of Biomedical and Molecular Science (DBMS), Queen’s University, Kingston, Ontario
2Department of Medicine, Queen’s University, Kingston, Ontario
3Queen’s CardioPulmonary Unit, Translational Institute of Medicine, Department of Medicine, Queen’s University, Kingston, Ontario, Canada
François Potus
4Pulmonary Hypertension Research Group, Center de Recherche de l’Institut Universitaire de Cardiologie et de Pneumologie de Québec, QC, Canada
Al-Qazazi Ruaa
2Department of Medicine, Queen’s University, Kingston, Ontario
Brooke Ring
3Queen’s CardioPulmonary Unit, Translational Institute of Medicine, Department of Medicine, Queen’s University, Kingston, Ontario, Canada
William C Nichols
5Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, and Department of Pediatrics; University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
Michael J Rauh
6Department of Pathology and Molecular Medicine, Queen’s University, Kingston, Ontario, Canada
Stephen L Archer
2Department of Medicine, Queen’s University, Kingston, Ontario
3Queen’s CardioPulmonary Unit, Translational Institute of Medicine, Department of Medicine, Queen’s University, Kingston, Ontario, Canada
Article usage
Posted August 13, 2023.
Humans with Pulmonary Arterial Hypertension display a global hypermethylation signature that worsens in patients who have a mutation in the gene encoding the methylation eraser, Tet Methylcytosine Dioxygenase 2 (TET2)
Charles C.T Hindmarch, François Potus, Al-Qazazi Ruaa, Brooke Ring, William C Nichols, Michael J Rauh, Stephen L Archer
medRxiv 2023.08.09.23293846; doi: https://doi.org/10.1101/2023.08.09.23293846
Humans with Pulmonary Arterial Hypertension display a global hypermethylation signature that worsens in patients who have a mutation in the gene encoding the methylation eraser, Tet Methylcytosine Dioxygenase 2 (TET2)
Charles C.T Hindmarch, François Potus, Al-Qazazi Ruaa, Brooke Ring, William C Nichols, Michael J Rauh, Stephen L Archer
medRxiv 2023.08.09.23293846; doi: https://doi.org/10.1101/2023.08.09.23293846
Subject Area
Subject Areas
- Addiction Medicine (401)
- Allergy and Immunology (712)
- Anesthesia (204)
- Cardiovascular Medicine (2965)
- Dermatology (250)
- Emergency Medicine (444)
- Epidemiology (12785)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4610)
- Geriatric Medicine (423)
- Health Economics (732)
- Health Informatics (2939)
- Health Policy (1070)
- Hematology (392)
- HIV/AIDS (927)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (474)
- Neurology (4392)
- Nursing (237)
- Nutrition (646)
- Oncology (2284)
- Ophthalmology (650)
- Orthopedics (259)
- Otolaryngology (327)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1199)
- Primary Care Research (501)
- Public and Global Health (6982)
- Radiology and Imaging (1539)
- Respiratory Medicine (917)
- Rheumatology (443)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (182)